Lenshil, Lenvatinib

Lenshil Lenvatinib is used for the treatment of thyroid cancer as a chemotherapy drug.

US Brand Name

Lenshil

Generic Name

Lenvatinib

Other Brand Name

Lenshil

Packing

Manufacturer

Shilpa Medicare Limited

Form

Capsule

Strength

4 mg, 10 mg, 12mg, 18mg

Country

India

4 mg 10 capsules USD $68.70

10 mg 10 capsules USD $155.60

12 mg 10 capsules USD $150.70

18 mg 10 capsules USD $209.60

Lenvatinib

Uses

Lenshil is used as a targeted therapy drug which is used for the treatment of metastatic and progressive thyroid cancer.

How it Works

Lenshil works to bind to tyrosine kinase receptors and it inhibits vascular epidermal growth factor receptors (VEGFR), VEGFR then inhibits other kinase receptors which have an effect on angiognesis, tumor growth and cancer progression. By binding to VEGFR receptors Lenshil works to block the pathways that promote cell division

Common Side effects

Some of the side effects related with taking Lenshil are as below

High blood pressure
Headache
Oral pain
Cough
Swelling
Rash
Taste changes
Dry mouth
Diarrhea
Fatigue
Vomiting
Abdominal pain
Joint/muscle aches
Decreased appetite
Weight loss
Nausea
Mouth sores
Dizziness
Heartburn
Hair loss

Expert advice

If you are experiencing a fever of 38 degrees Celsius or higher, experiencing shortness of breath, chest pains or pains in your arms,weakness in one side of the body or sudden vision changes please go to the emergency room immediately.